Answer
No. Pembrolizumab is an immune checkpoint inhibitor that helps T cells recognise and attack susceptible cancer cells. It may, however, be given alongside chemotherapy or other cancer treatments.
Sources for this answer
- KEYTRUDA 25 mg/mL concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.